Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant

  • Authors:
    • Jaime Carcel-Trullols
    • Joseph S. Stanley
    • Rinku Saha
    • Saeid Shaaf
    • Manali S. Bendre
    • Behjatolah Monzavi-Karbassi
    • Larry J. Suva
    • Thomas Kieber-Emmons
  • View Affiliations

  • Published online on: May 1, 2006     https://doi.org/10.3892/ijo.28.5.1173
  • Pages: 1173-1183
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The mechanisms that guide organ-specific metastases are not fully established. The aberrant expression of carbohydrates may play a fundamental role in defining the molecular mechanisms for metastases to distant organs and facilitate positive interactions within the target organ. The purpose of the present study was to determine the glycomic profile of a variant of the MDA-MB-231 breast cancer cell line that colonizes the bone and to ascribe mechanistic functions mediated by carbohydrates that might correlate with clinical bone metastases. The carbohydrate expression profiles of osteolytic MDA-MET breast cancer cells and non-osteolytic parental MDA-MB-231 cells were determined. MDA-MET cells were derived from MDA-MB-231 cells by in vivo selection of metastatic bone lesions following intracardiac inoculation. The two related breast cancer cell lines expressed distinct carbohydrate profiles; MDA-MET cells displayed an increased expression of alpha (2,6) linked sialic acid, N-β1-6 GlcNAc, and sialylated Lewis-A antigen, and decreased expression of Galβ1,3GalNAc as detected using a combination of lectins and anti-carbohydrate antibodies. Microarray analysis demonstrated an increased expression of glycosyltransferase genes, correlative for the distinct glycomic phenotype. The altered glycomic phenotypes of MDA-MET cells include effects on the differential binding to bone marrow endothelial cells, enhanced ECM binding and an increase in invasive potential. These data suggest that the glycomic phenotype of MDA-MET cells is associated with a select set of accumulated functions that collectively impact on the bone metastases and bone colonization capacity of breast cancer cells.

Related Articles

Journal Cover

May 2006
Volume 28 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Carcel-Trullols, J., Stanley, J.S., Saha, R., Shaaf, S., Bendre, M.S., Monzavi-Karbassi, B. ... Kieber-Emmons, T. (2006). Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. International Journal of Oncology, 28, 1173-1183. https://doi.org/10.3892/ijo.28.5.1173
MLA
Carcel-Trullols, J., Stanley, J. S., Saha, R., Shaaf, S., Bendre, M. S., Monzavi-Karbassi, B., Suva, L. J., Kieber-Emmons, T."Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant". International Journal of Oncology 28.5 (2006): 1173-1183.
Chicago
Carcel-Trullols, J., Stanley, J. S., Saha, R., Shaaf, S., Bendre, M. S., Monzavi-Karbassi, B., Suva, L. J., Kieber-Emmons, T."Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant". International Journal of Oncology 28, no. 5 (2006): 1173-1183. https://doi.org/10.3892/ijo.28.5.1173